Troglitazone has a scavenging effect on reactive oxygen species

Area of Science:

• Biochemistry
• Pharmacology
• Oxidative Stress

Background:

• Troglitazone is a thiazolidinedione derivative developed to improve insulin sensitivity.
• Its molecular structure resembles known antioxidants like alpha-tocopherol and probucol.
• Previous studies indicated in vitro antioxidant activity in specific animal models.

Purpose of the Study:

• To investigate the antioxidant capacity of troglitazone.
• To compare the antioxidant effects of troglitazone with pioglitazone, another thiazolidinedione.
• To explore the potential benefits of troglitazone's antioxidant action in managing diabetic complications.

Main Methods:

• Assessing troglitazone's scavenging effect on reactive oxygen species generated by xanthine-xanthine oxidase.
• Evaluating troglitazone's effect on reactive oxygen species produced by stimulated neutrophils.
• Comparing these effects with those of pioglitazone under identical conditions.

Main Results:

• Troglitazone exhibited significant scavenging activity against reactive oxygen species.
• The antioxidant effect of troglitazone was comparable to that of alpha-tocopherol.
• Pioglitazone did not demonstrate similar reactive oxygen species scavenging properties under the tested conditions.

Conclusions:

• Troglitazone possesses antioxidant properties, likely due to its structural similarity to alpha-tocopherol.
• This antioxidant capability may offer additional therapeutic benefits beyond its hypoglycemic and hypolipidemic effects.
• Troglitazone's antioxidant action could be valuable in preventing vascular complications associated with diabetes.